Discounted Cash Flow
Organogenesis Holdings Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $0 | $-208.7k | $-1.9m | — | $-0.03 |
| 2017 | $0 | $-2.1m (-903.3%) | $-3.0m (-56.6%) | — | $-0.48 (-1500.0%) |
| 2018 | $193.4m | $-64.8m (-2996.2%) | $-62.6m (-1977.8%) | -33.5% | $-0.94 (-95.8%) |
| 2019 | $261.0m (34.9%) | $-40.5m (37.6%) | $-39.5m (36.9%) | -15.5% (53.7%) | $-0.44 (53.2%) |
| 2020 | $338.3m (29.6%) | $17.9m (144.4%) | $-14.3m (63.7%) | 5.3% (134.2%) | $0.17 (138.6%) |
| 2021 | $468.1m (38.4%) | $94.9m (428.7%) | $30.8m (314.4%) | 20.3% (282.2%) | $0.74 (335.3%) |
| 2022 | $450.9m (-3.7%) | $15.5m (-83.6%) | $-9.0m (-129.4%) | 3.4% (-83.0%) | $0.12 (-83.8%) |
| 2023 | $433.1m (-3.9%) | $4.9m (-68.2%) | $6.6m (172.5%) | 1.1% (-66.9%) | $0.04 (-66.7%) |
| 2024 | $482.0m (11.3%) | $861.0k (-82.6%) | $4.2m (-36.3%) | 0.2% (-84.4%) | $-0.01 (-125.0%) |
| 2025 | $564.2m (17.0%) | $37.0m (4201.0%) | $-24.5m (-685.7%) | 6.6% (3574.9%) | $0.16 (1700.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.